Dr Escriu is a highly experienced Consultant Medical Oncologist specialising in lung cancer, mesothelioma, and thymic malignancies. With over a decade of extensive clinical expertise, he offers personalised, evidence-based care, combining the latest research with a compassionate and honest approach. His goal is to maximise treatment options while ensuring patients feel supported and informed throughout their journey.

 

He completed a PhD in cancer biology at the University of Cambridge and is a Fellow of the Royal College of Physicians of London. Dr Escriu has led and contributed to numerous clinical trials and research initiatives, ensuring patients have access to innovative therapies through the latest technology in genetic and molecular profiling.

 

Dr Escriu is a regional lead for thoracic research and regularly lectures at national and international conferences, where he benchmarks his practice against the highest global standards. He works closely with multidisciplinary teams to deliver tailored treatment plans and is deeply committed to clinical excellence and patient wellbeing.

GMC number: 6031963